ArticleMolecular pharmaceutics2015

Selective Tumor Targeting of Desacetyl Vinblastine Hydrazide and Tubulysin B via Conjugation to a Cholecystokinin 2 Receptor (CCK2R) Ligand.

Charity Wayua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.